Paper36918828
Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z and 10 others. BMC Cancer, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols. Papers, record 36918828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36918828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endometrial Neoplasms | Major topic |
| Female | |
| Humans | |
| Prognosis | |
| Retrospective Studies | |
| Progression-Free Survival | |
| Mutation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PX2018039 | Beijing Municipal Administration of Hospitals Incubating Program | PubMed | ||
| QML20210902 | Beijing Hospitals Authority Youth Programme | PubMed | ||
| 2022TS003 | Tsinghua University Precision Medicine Research Program Exploration Project | PubMed |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34746222 | Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer. | Front Surg | 2021 | https://conductscience.org/library/papers/34746222 | PubMed |
| 2 | 25826470 | Dietary components and uterine leiomyomas: a review of published data. | Nutr Cancer | 2015 | https://conductscience.org/library/papers/25826470 | PubMed |
| 3 | 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 | https://conductscience.org/library/papers/36731023 | PubMed |
| 4 | 35992873 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35992873 | PubMed |
| 5 | 32620514 | British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice. | Eur J Obstet Gynecol Reprod Biol | 2020 | https://conductscience.org/library/papers/32620514 | PubMed |
| 6 | 33662372 | Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier. | Hum Pathol | 2021 | https://conductscience.org/library/papers/33662372 | PubMed |
| 7 | 23636398 | Integrated genomic characterization of endometrial carcinoma. | Nature | 2013 | https://conductscience.org/library/papers/23636398 | PubMed |
| 8 | 27020214 | Early changes of endometrial neoplasia revealed by loss of mismatch repair gene protein expression in a patient diagnosed with Lynch syndrome. | Pathology | 2016 | https://conductscience.org/library/papers/27020214 | PubMed |
| 9 | 34790235 | Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer. | J Oncol | 2021 | https://conductscience.org/library/papers/34790235 | PubMed |
| 10 | 31326637 | Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series. | Eur J Obstet Gynecol Reprod Biol | 2019 | https://conductscience.org/library/papers/31326637 | PubMed |
| 11 | 29045681 | International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013. | J Natl Cancer Inst | 2018 | https://conductscience.org/library/papers/29045681 | PubMed |
| 12 | 35365770 | Genomic landscape of endometrial carcinomas of no specific molecular profile. | Mod Pathol | 2022 | https://conductscience.org/library/papers/35365770 | PubMed |
| 13 | 26166718 | The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility. | Int J Gynecol Pathol | 2016 | https://conductscience.org/library/papers/26166718 | PubMed |
| 14 | 34420863 | Adjuvant and post-surgical treatment in endometrial cancer. | Best Pract Res Clin Obstet Gynaecol | 2022 | https://conductscience.org/library/papers/34420863 | PubMed |
| 15 | 17527071 | Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. | Am J Surg Pathol | 2007 | https://conductscience.org/library/papers/17527071 | PubMed |
| 16 | 34673912 | A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas. | Arch Pathol Lab Med | 2021 | https://conductscience.org/library/papers/34673912 | PubMed |
| 17 | 29432521 | Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29432521 | PubMed |
| 18 | 35078648 | Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment. | Gynecol Oncol | 2022 | https://conductscience.org/library/papers/35078648 | PubMed |
| 19 | 30387875 | Risk factors for endometrial cancer: An umbrella review of the literature. | Int J Cancer | 2019 | https://conductscience.org/library/papers/30387875 | PubMed |
| 20 | 34073635 | New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34073635 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42022325 | Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance. | Front Oncol | 2026 | https://conductscience.org/library/papers/42022325 | PubMed |
| 41394227 | Analysis of the Clinicopathological Characteristics of Different Molecular Subtypes in Endometrial Cancer: A Retrospective Single Center Study. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/41394227 | PubMed |
| 41153317 | Epidemiological and Histopathological Characterization of Endometrial Carcinoma: A Retrospective Cohort from Romania. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41153317 | PubMed |
| 40321963 | The prognostic implication of polymerase epsilon-mutated endometrial cancer. | Tzu Chi Med J | 2025 | https://conductscience.org/library/papers/40321963 | PubMed |
| 40072110 | The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers. | Cells | 2025 | https://conductscience.org/library/papers/40072110 | PubMed |
| 39990931 | Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes. | Int J Womens Health | 2025 | https://conductscience.org/library/papers/39990931 | PubMed |
| 39294393 | Clinical characteristics and genomic profiling of outpatients with endometrial cancer at a Chinese tertiary cancer center. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39294393 | PubMed |
| 39176196 | Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer. | Rev Bras Ginecol Obstet | 2024 | https://conductscience.org/library/papers/39176196 | PubMed |
| 39045330 | A disulfidptosis-related lncRNAs cluster to forecast the prognosis and immune landscapes of ovarian cancer. | Front Genet | 2024 | https://conductscience.org/library/papers/39045330 | PubMed |
| 38974111 | KIF2A correlates with lymphovascular invasion and higher tumor stage, and can be used to predict worse prognosis in patients with endometrial carcinoma. | Oncol Lett | 2024 | https://conductscience.org/library/papers/38974111 | PubMed |
| 37894913 | Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894913 | PubMed |
| 37298731 | Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298731 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36918828
GET https://conductscience.org/api/papers/v1/36918828/references?page=2